Anush Sridharan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anush Sridharan has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Flemming Forsberg
Department of Radiology, Thomas Jefferson University, Philadelphia, PA, 19107, USA
15 shared publications John R. Eisenbrey
From the Departments of Radiology (K.N., J.R.E., M.S., A.S., F.F.), Surgery (A.C.B.), Medical Oncology (T.A.), and Pathology (J.P.P.), Thomas Jefferson University, 763H Main Building, 132 S 10th St, Philadelphia, PA 19107; and Department of Electrical and Computer Engineering, Drexel University, Philadelphia, Pa (A.S.).
14 shared publicationsPriscilla Machado
Radiology, Thomas Jefferson University, Philadelphia, PA, USA
10 shared publicationsKirk Wallace
GE Global Research, Niskayuna, NY, USA
9 shared publicationsAlexander Sevrukov
Department of Radiology, Thomas Jefferson University, 763H Main Building, 132 South 10th Street, Philadelphia, PA 19107
7 shared publicationsAnnina Wilkes
Department of Radiology, Thomas Jefferson University, 763H Main Building, 132 South 10th Street, Philadelphia, PA 19107
7 shared publications
Latest Publications
- Open Access
Evolving Trends in Early-Onset and Young Adult Gastrointestinal Cancer: Philadelphia in a National Context
Background: Early-onset (EO) GI malignancies, especially in younger adults, have increased in the past several decades, with advanced stages at diagnosis and aggressive tumor features relative to patients with average-age-onset disease. Methods: We performed a retrospective analysis of patients aged 18–44 years diagnosed with a GI malignancy within TUHS between 2010 and 2025 and compared with data via the National Cancer Database. Results: A total of 530 pts at TUHS and 81,097 in the NCDB were included. Average age at diagnosis was higher at TUHS (37.6 vs. 32.9 years). Compared with NCDB, TUHS also saw a greater proportion of Black patients (22.1% vs. 15.5%). TUHS patients presented with more advanced stages at diagnosis, with more stage III (27.4% vs. 12.6%) and stage IV disease (33.8% vs. 22.1%). Among those that were insured, patients at TUHS saw more reliance on government insurance (30.3 vs. 27.5%) compared to the rates from NCDB. Although unadjusted time from diagnosis to treatment was longer at TUHS, this difference was not statistically significant after adjustment. More specifically, this duration was longer for Black patients by nearly 7 days compared with the national average (31.77 vs. 24.62 days). Conclusions: TUHS had a similar cancer case distribution compared to national counterparts, but was characterized by more advanced stages at diagnosis and longer time to treatment. These findings necessitate investigation into potential structural and sociodemographic factors that may contribute to delayed diagnosis and inequities in care. Targeted interventions are urgently needed to mitigate the growing burden of EO GI cancers in underserved populations.
Open AccessEvolving Trends in Early-Onset and Young Adult Gastrointestinal Cancer: Philadelphia in a National Context
Background: Early-onset (EO) GI malignancies, especially in younger adults, have increased in the past several decades, with advanced stages at diagnosis and aggressive tumor features relative to patients with average-age-onset disease. Methods: We performed a retrospective analysis of patients aged 18–44 years diagnosed with a GI malignancy within TUHS between 2010 and 2025 and compared with data via the National Cancer Database. Results: A total of 530 pts at TUHS and 81,097 in the NCDB were included. Average age at diagnosis was higher at TUHS (37.6 vs. 32.9 years). Compared with NCDB, TUHS also saw a greater proportion of Black patients (22.1% vs. 15.5%). TUHS patients presented with more advanced stages at diagnosis, with more stage III (27.4% vs. 12.6%) and stage IV disease (33.8% vs. 22.1%). Among those that were insured, patients at TUHS saw more reliance on government insurance (30.3 vs. 27.5%) compared to the rates from NCDB. Although unadjusted time from diagnosis to treatment was longer at TUHS, this difference was not statistically significant after adjustment. More specifically, this duration was longer for Black patients by nearly 7 days compared with the national average (31.77 vs. 24.62 days). Conclusions: TUHS had a similar cancer case distribution compared to national counterparts, but was characterized by more advanced stages at diagnosis and longer time to treatment. These findings necessitate investigation into potential structural and sociodemographic factors that may contribute to delayed diagnosis and inequities in care. Targeted interventions are urgently needed to mitigate the growing burden of EO GI cancers in underserved populations.
- 28 April 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (4) , 647-656
Association of Contrast-Enhanced Ultrasound–Derived Kidney Cortical Microvascular Perfusion with Kidney Function
Background: Individuals with chronic kidney disease (CKD) have decreased kidney cortical microvascular perfusion, which may lead to worsening kidney function over time, but methods to quantify kidney cortical microvascular perfusion are not feasible to incorporate into clinical practice. Contrast-enhanced ultrasound (CEUS) may quantify kidney cortical microvascular perfusion, which requires further investigation in individuals across the spectrum of kidney function. Methods: We performed CEUS on a native kidney of 83 individuals across the spectrum of kidney function and calculated quantitative CEUS-derived kidney cortical microvascular perfusion biomarkers. Participants had a continuous infusion of the microbubble contrast agent (Definity) with a flash-replenishment sequence during their CEUS scan. Lower values of the microbubble velocity (β) and perfusion index (β×A) may represent lower kidney cortical microvascular perfusion. Multivariable linear regression models tested the associations of the microbubble velocity (β) and perfusion index (β×A) with estimated glomerular filtration rate (eGFR). Results: Thirty-eight individuals with CKD (mean age±SD 65.2±12.6 years, median [IQR] eGFR 31.5 [18.9–41.5] ml/min per 1.73 m2), 37 individuals with end stage kidney disease (ESKD; age 54.8±12.3 years), and eight healthy volunteers (age 44.1±15.0 years, eGFR 117 [106–120] ml/min per 1.73 m2) underwent CEUS without side effects. Individuals with ESKD had the lowest microbubble velocity (β) and perfusion index (β×A) compared with individuals with CKD and healthy volunteers. The microbubble velocity (β) and perfusion index (β×A) had moderate positive correlations with eGFR (β: r s=0.44, Pβ×A: r s=0.50, Pβ) and perfusion index (β×A) remained significantly associated with eGFR (change in natural log transformed eGFR per 1 unit increase in natural log transformed biomarker: β, 0.38 [95%, CI 0.17 to 0.59]; β×A, 0.79 [95% CI, 0.45 to 1.13]). Conclusions: CEUS-derived kidney cortical microvascular perfusion biomarkers are associated with eGFR. Future studies are needed to determine if CEUS-derived kidney cortical microvascular perfusion biomarkers have prognostic value.
- 28 April 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (4) , 647-656
Association of Contrast-Enhanced Ultrasound–Derived Kidney Cortical Microvascular Perfusion with Kidney Function
Background: Individuals with chronic kidney disease (CKD) have decreased kidney cortical microvascular perfusion, which may lead to worsening kidney function over time, but methods to quantify kidney cortical microvascular perfusion are not feasible to incorporate into clinical practice. Contrast-enhanced ultrasound (CEUS) may quantify kidney cortical microvascular perfusion, which requires further investigation in individuals across the spectrum of kidney function. Methods: We performed CEUS on a native kidney of 83 individuals across the spectrum of kidney function and calculated quantitative CEUS-derived kidney cortical microvascular perfusion biomarkers. Participants had a continuous infusion of the microbubble contrast agent (Definity) with a flash-replenishment sequence during their CEUS scan. Lower values of the microbubble velocity (β) and perfusion index (β×A) may represent lower kidney cortical microvascular perfusion. Multivariable linear regression models tested the associations of the microbubble velocity (β) and perfusion index (β×A) with estimated glomerular filtration rate (eGFR). Results: Thirty-eight individuals with CKD (mean age±SD 65.2±12.6 years, median [IQR] eGFR 31.5 [18.9–41.5] ml/min per 1.73 m2), 37 individuals with end stage kidney disease (ESKD; age 54.8±12.3 years), and eight healthy volunteers (age 44.1±15.0 years, eGFR 117 [106–120] ml/min per 1.73 m2) underwent CEUS without side effects. Individuals with ESKD had the lowest microbubble velocity (β) and perfusion index (β×A) compared with individuals with CKD and healthy volunteers. The microbubble velocity (β) and perfusion index (β×A) had moderate positive correlations with eGFR (β: r s=0.44, Pβ×A: r s=0.50, Pβ) and perfusion index (β×A) remained significantly associated with eGFR (change in natural log transformed eGFR per 1 unit increase in natural log transformed biomarker: β, 0.38 [95%, CI 0.17 to 0.59]; β×A, 0.79 [95% CI, 0.45 to 1.13]). Conclusions: CEUS-derived kidney cortical microvascular perfusion biomarkers are associated with eGFR. Future studies are needed to determine if CEUS-derived kidney cortical microvascular perfusion biomarkers have prognostic value.
- 1 December 2021
- Published by Wolters Kluwer Health in Ultrasound Quarterly
- Vol. 37 (4) , 315-323
Advanced Ultrasound Techniques for Differentiation of Benign Versus Malignant Thyroid Nodules
Grayscale ultrasound (US) is decisive in stratifying which thyroid nodules benefit from fine-needle aspiration to evaluate for malignancy. Unfortunately, a significant percentage of nodules remain indeterminate. Herein, we review the clinical considerations and diagnostic accuracy of advanced US, Doppler US, contrast-enhanced US, and US elastography techniques in the evaluation of indeterminate nodules. We conclude that these techniques may be used in combination with grayscale US to improve the assessment of lesion vascularity and tissue property.
- 1 December 2021
- Published by Wolters Kluwer Health in Ultrasound Quarterly
- Vol. 37 (4) , 315-323
Advanced Ultrasound Techniques for Differentiation of Benign Versus Malignant Thyroid Nodules
Grayscale ultrasound (US) is decisive in stratifying which thyroid nodules benefit from fine-needle aspiration to evaluate for malignancy. Unfortunately, a significant percentage of nodules remain indeterminate. Herein, we review the clinical considerations and diagnostic accuracy of advanced US, Doppler US, contrast-enhanced US, and US elastography techniques in the evaluation of indeterminate nodules. We conclude that these techniques may be used in combination with grayscale US to improve the assessment of lesion vascularity and tissue property.
- Open Access
- 1 August 2021
- Published by Paul V. Galvin Library/Illinois Institute of Technology in 14th International Symposium on Particle Image Velocimetry
- Vol. 1 (1)
Visualization and Quantification of the Cerebral Microcirculation using Contrast-enhanced Ultrasound Particle Tracking Velocimetry
Noninvasive measurements of the regional microvascular perfusion might lead to sensitive biomarkers for the changes in intracranial hemodynamics that could guide timely surgical interventions for neonatal brain injuries. The current work utilizes a clinically available contrast enhanced ultrasound (CEUS) system and particle tracking velocimetry to perform ultrasound localization microscopy for measuring the microcirculation in piglets. A new deep learning method based on U-net is proposed for enhancing noisy raw CEUS images and detecting the microbubbles. Subsequently, the bubbles are tracked using a Kalman filter based method, which incorporates conditions of spatio-temporal consistency in flow direction and globally optimizes the assignment of bubbles to trajectories. Based on analysis of synthetic data, the U-net results demonstrate significant improvement in the processing speed and localization accuracy over a conventional blind deconvolution method. Visualization of the microvasculature is performed by superposing the bubble trajectories, enabling depiction of a complex micro-vessel network, where neighboring vessels separated by 40 µm can be distinguished. The corresponding perfusion map shows the velocity distribution in these vessels. Based on the current frame rate (44 fps), speeds in the 0.1 to 12 cm/s range can be well captured. These methods show promise as potential clinical tools for bedside measurement of cerebral microcirculation.
- 1 August 2021
- Published by Paul V. Galvin Library/Illinois Institute of Technology in 14th International Symposium on Particle Image Velocimetry
- Vol. 1 (1)
Open AccessVisualization and Quantification of the Cerebral Microcirculation using Contrast-enhanced Ultrasound Particle Tracking Velocimetry
Noninvasive measurements of the regional microvascular perfusion might lead to sensitive biomarkers for the changes in intracranial hemodynamics that could guide timely surgical interventions for neonatal brain injuries. The current work utilizes a clinically available contrast enhanced ultrasound (CEUS) system and particle tracking velocimetry to perform ultrasound localization microscopy for measuring the microcirculation in piglets. A new deep learning method based on U-net is proposed for enhancing noisy raw CEUS images and detecting the microbubbles. Subsequently, the bubbles are tracked using a Kalman filter based method, which incorporates conditions of spatio-temporal consistency in flow direction and globally optimizes the assignment of bubbles to trajectories. Based on analysis of synthetic data, the U-net results demonstrate significant improvement in the processing speed and localization accuracy over a conventional blind deconvolution method. Visualization of the microvasculature is performed by superposing the bubble trajectories, enabling depiction of a complex micro-vessel network, where neighboring vessels separated by 40 µm can be distinguished. The corresponding perfusion map shows the velocity distribution in these vessels. Based on the current frame rate (44 fps), speeds in the 0.1 to 12 cm/s range can be well captured. These methods show promise as potential clinical tools for bedside measurement of cerebral microcirculation.
- 15 May 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (12) , 2425-2436
Translational research in pediatric contrast-enhanced ultrasound
The role of contrast-enhanced ultrasound (CEUS) imaging is being widely explored by various groups for its use in the pediatric population. Clinical implementation of new diagnostic or therapeutic techniques requires extensive and meticulous preclinical testing and evaluation. The impact of CEUS will be determined in part by the extent to which studies are oriented specifically toward a pediatric population. Rather than simply applying principles and techniques used in the adult population, these studies are expected to advance and augment preexisting knowledge with pediatric-specific information. To further develop this imaging modality for use in children, pediatric-focused preclinical research is essential. In this paper we describe the development and implementation of the pediatric-specific preclinical animal and phantom models that are being used to evaluate CEUS with the goal of clinical translation to children.
- 15 May 2021
- Published by Springer Nature in Pediatric Radiology
- Vol. 51 (12) , 2425-2436
Translational research in pediatric contrast-enhanced ultrasound
The role of contrast-enhanced ultrasound (CEUS) imaging is being widely explored by various groups for its use in the pediatric population. Clinical implementation of new diagnostic or therapeutic techniques requires extensive and meticulous preclinical testing and evaluation. The impact of CEUS will be determined in part by the extent to which studies are oriented specifically toward a pediatric population. Rather than simply applying principles and techniques used in the adult population, these studies are expected to advance and augment preexisting knowledge with pediatric-specific information. To further develop this imaging modality for use in children, pediatric-focused preclinical research is essential. In this paper we describe the development and implementation of the pediatric-specific preclinical animal and phantom models that are being used to evaluate CEUS with the goal of clinical translation to children.
- 16 December 2020
- Published by Wolters Kluwer Health in Ultrasound Quarterly
- Vol. 38 (1) , 31-35
Brain Contrast-Enhanced Ultrasound Evaluation of a Pediatric Swine Model
Brain injury remains a leading cause of morbidity and mortality in children. We evaluated the feasibility of using a pediatric swine model to develop contrast-enhanced ultrasound (CEUS)–based measures of brain perfusion for clinical application in various types of brain injury monitoring. Six-week-old, 10-kg swine (N = 10) were anesthetized, and an acoustic window was created in the right frontal cranium to provide visualization of an oblique coronal plane and bilateral thalami. Ultrasound contrast agent was administered via a femoral venous catheter as a weight-based (0.03 mL/kg) bolus. After localization of the imaging plane, CEUS cine clips were acquired for 90 seconds. Bolus injection of contrast agent provided global visualization of cerebral perfusion and highlighted microvasculature in the brain. Preliminary evaluation of bolus kinetics in piglets showed a central gray nuclei–to–cortex ratio similar to human infants with a steep wash-in that crossed and remained above the 1.0 threshold for most of the enhancement period. We demonstrated the similarity in brain perfusion between piglets and human infants, specifically central gray nuclei–to–cortex ratio, showing preliminary feasibility of its use as a pediatric model of brain perfusion. Contrast-enhanced ultrasound can be performed at the bedside as a minimally invasive procedure, and quantitative CEUS may provide critical information regarding changes in brain perfusion as a result of injury or as a response to therapy.
- 16 December 2020
- Published by Wolters Kluwer Health in Ultrasound Quarterly
- Vol. 38 (1) , 31-35
Brain Contrast-Enhanced Ultrasound Evaluation of a Pediatric Swine Model
Brain injury remains a leading cause of morbidity and mortality in children. We evaluated the feasibility of using a pediatric swine model to develop contrast-enhanced ultrasound (CEUS)–based measures of brain perfusion for clinical application in various types of brain injury monitoring. Six-week-old, 10-kg swine (N = 10) were anesthetized, and an acoustic window was created in the right frontal cranium to provide visualization of an oblique coronal plane and bilateral thalami. Ultrasound contrast agent was administered via a femoral venous catheter as a weight-based (0.03 mL/kg) bolus. After localization of the imaging plane, CEUS cine clips were acquired for 90 seconds. Bolus injection of contrast agent provided global visualization of cerebral perfusion and highlighted microvasculature in the brain. Preliminary evaluation of bolus kinetics in piglets showed a central gray nuclei–to–cortex ratio similar to human infants with a steep wash-in that crossed and remained above the 1.0 threshold for most of the enhancement period. We demonstrated the similarity in brain perfusion between piglets and human infants, specifically central gray nuclei–to–cortex ratio, showing preliminary feasibility of its use as a pediatric model of brain perfusion. Contrast-enhanced ultrasound can be performed at the bedside as a minimally invasive procedure, and quantitative CEUS may provide critical information regarding changes in brain perfusion as a result of injury or as a response to therapy.
- 1 August 2020
- Published by Elsevier in Academic Radiology
- Vol. 27 (8) , 1065-1074
Characterizing Breast Lesions Using Quantitative Parametric 3D Subharmonic Imaging: A Multicenter Study
- 1 August 2020
- Published by Elsevier in Academic Radiology
- Vol. 27 (8) , 1065-1074
Characterizing Breast Lesions Using Quantitative Parametric 3D Subharmonic Imaging: A Multicenter Study
- 1 October 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1177-1180
Combining Quantitative 3D Subharmonic Imaging and Clinical Assessments for Accurate Characterization of Breast Masses
This multi-center study evaluated the ability of contrast-enhanced, nonlinear 3D ultrasound imaging to characterize indeterminate breast lesions using quantitative parametric maps and clinical assessments. In total 236 women with biopsy-proven breast lesions were enrolled in this study. Following B-mode and power Doppler imaging (PDI), an ultrasound contrast agent (Definity®, Lantheus Medical Imaging, N Billerica, MA, USA) was administrated. Contrast-enhanced 3D harmonic imaging (HI; transmitting/receiving at 5.0/10.0 MHz) as well as 3D subharmonic imaging (SHI; transmitting/receiving at 5.8/2.9 MHz) were performed using a modified Logiq 9 scanner (GE Healthcare, Waukesha, WI, USA) with a 4D10L probe. Five radiologists blinded to the reference independently scored the imaging modes using a 7-point BIRADS scale. Parametric volumes were constructed from time-intensity curves for vascular heterogeneity, perfusion (PER as the slope of the curve) and area under the curve (AUC) based on individual voxel values in the lesion. ROC analysis were applied to assess diagnostic accuracy with biopsy results as the reference. Out of the 236 cases, 219 were successfully scanned and biopsies resulted in 164 (75%) benign and 55 (25%) malignant lesions. 3D HI showed flow in 8 lesions (5 benign and 3 malignant), whereas 3D SHI visualized flow in 83 lesions (58 benign and 25 malignant). Hence, extracting quantitative parameters was restricted to the SHI volumes that demonstrated sufficient flow for processing. Diagnostic accuracy for the quantitative SHI parameters ranged from 0.52 to 0.75. Diagnostic accuracies from the clinical assessments ranged from 0.55-0.94 for baseline ultrasound, 0.52-0.93 for PDI, 0.59-0.85 for HI and 0.55-0.91 for SHI. The best logistical regression model achieved an accuracy of 0.91. In conclusion, combining quantitative SHI perfusion estimates and conventional B-mode imaging may increase the accuracy for characterizing indeterminate breast masses.
- 1 October 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1177-1180
Combining Quantitative 3D Subharmonic Imaging and Clinical Assessments for Accurate Characterization of Breast Masses
This multi-center study evaluated the ability of contrast-enhanced, nonlinear 3D ultrasound imaging to characterize indeterminate breast lesions using quantitative parametric maps and clinical assessments. In total 236 women with biopsy-proven breast lesions were enrolled in this study. Following B-mode and power Doppler imaging (PDI), an ultrasound contrast agent (Definity®, Lantheus Medical Imaging, N Billerica, MA, USA) was administrated. Contrast-enhanced 3D harmonic imaging (HI; transmitting/receiving at 5.0/10.0 MHz) as well as 3D subharmonic imaging (SHI; transmitting/receiving at 5.8/2.9 MHz) were performed using a modified Logiq 9 scanner (GE Healthcare, Waukesha, WI, USA) with a 4D10L probe. Five radiologists blinded to the reference independently scored the imaging modes using a 7-point BIRADS scale. Parametric volumes were constructed from time-intensity curves for vascular heterogeneity, perfusion (PER as the slope of the curve) and area under the curve (AUC) based on individual voxel values in the lesion. ROC analysis were applied to assess diagnostic accuracy with biopsy results as the reference. Out of the 236 cases, 219 were successfully scanned and biopsies resulted in 164 (75%) benign and 55 (25%) malignant lesions. 3D HI showed flow in 8 lesions (5 benign and 3 malignant), whereas 3D SHI visualized flow in 83 lesions (58 benign and 25 malignant). Hence, extracting quantitative parameters was restricted to the SHI volumes that demonstrated sufficient flow for processing. Diagnostic accuracy for the quantitative SHI parameters ranged from 0.52 to 0.75. Diagnostic accuracies from the clinical assessments ranged from 0.55-0.94 for baseline ultrasound, 0.52-0.93 for PDI, 0.59-0.85 for HI and 0.55-0.91 for SHI. The best logistical regression model achieved an accuracy of 0.91. In conclusion, combining quantitative SHI perfusion estimates and conventional B-mode imaging may increase the accuracy for characterizing indeterminate breast masses.
- Open Access
- 20 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
Here we report an ultra-long-acting tunable, biodegradable, and removable polymer-based delivery system that offers sustained drug delivery for up to one year for HIV treatment or prophylaxis. This robust formulation offers the ability to integrate multiple drugs in a single injection, which is particularly important to address the potential for drug resistance with monotherapy. Six antiretroviral drugs were selected based on their solubility inN-methyl-2-pyrrolidone and relevance as a combination therapy for HIV treatment or prevention. All drugs released with concentrations above their protein-adjusted inhibitory concentration and retained their physical and chemical properties within the formulation and upon release. The versatility of this formulation to integrate multiple drugs and provide sustained plasma concentrations from several weeks to up to one year, combined with its ability to be removed to terminate the treatment if necessary, makes it attractive as a drug delivery platform technology for a wide range of applications.
- 20 September 2019
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-12
Open AccessUltra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
Here we report an ultra-long-acting tunable, biodegradable, and removable polymer-based delivery system that offers sustained drug delivery for up to one year for HIV treatment or prophylaxis. This robust formulation offers the ability to integrate multiple drugs in a single injection, which is particularly important to address the potential for drug resistance with monotherapy. Six antiretroviral drugs were selected based on their solubility inN-methyl-2-pyrrolidone and relevance as a combination therapy for HIV treatment or prevention. All drugs released with concentrations above their protein-adjusted inhibitory concentration and retained their physical and chemical properties within the formulation and upon release. The versatility of this formulation to integrate multiple drugs and provide sustained plasma concentrations from several weeks to up to one year, combined with its ability to be removed to terminate the treatment if necessary, makes it attractive as a drug delivery platform technology for a wide range of applications.
- 17 December 2018
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 38 (8) , 1971-1978
Contrast‐Enhanced Ultrasound in Extracorporeal Support: In Vitro Studies and Initial Experience and Safety Data in the Extreme Premature Fetal Lamb Maintained by the Extrauterine Environment for Neonatal Development
Objectives: To evaluate the effects of ultrasound contrast agent (UCA) administration on hemodynamic parameters and support equipment in in vitro and in vivo models of extracorporeal support.Methods: In vitro, incrementally increasing bolus doses of a UCA were administered proximal to a membrane oxygenator, and ultrasound cine clips were obtained. The rates of microbubble destruction across the oxygenator and over time were calculated from time‐intensity‐curves. Measurements across the membrane oxygenator were recorded and compared by a repeated‐measures analysis of variance. In vivo, 7 premature fetal lambs were transferred from placental support to the extrauterine environment for neonatal development. Contrast agent boluses were administered for contrast‐enhanced ultrasound (CEUS) examinations. Hemodynamic parameters and serum laboratory values were evaluated before and after the examinations by paired t tests. For oxygenator staining, oxygenator membranes from the in vitro circuit, study animals (n = 4), and control animals (n = 4) were stained for the adherent UCA.Results: In vitro, with all doses (0.1–4 mL), there was no difference in measured parameters across the oxygenator (P ≥ .09). Contrast agent destruction (3%–14%) across the oxygenator was observed at the first pass with a progressive decline in contrast intensity over time. In vivo, there was no difference in hemodynamic parameters or serum laboratory values (P ≥ .08) with any CEUS examination (n = 17). For oxygenator staining, all oxygenator membranes were negative for UCA with lipid staining.Conclusions: The UCA had no detectable effect on the oxygenator or measured parameters in in vitro and in vivo studies, thus providing additional safety data to support the use of CEUS in the setting of extracorporeal support.
- 17 December 2018
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 38 (8) , 1971-1978
Contrast‐Enhanced Ultrasound in Extracorporeal Support: In Vitro Studies and Initial Experience and Safety Data in the Extreme Premature Fetal Lamb Maintained by the Extrauterine Environment for Neonatal Development
Objectives: To evaluate the effects of ultrasound contrast agent (UCA) administration on hemodynamic parameters and support equipment in in vitro and in vivo models of extracorporeal support.Methods: In vitro, incrementally increasing bolus doses of a UCA were administered proximal to a membrane oxygenator, and ultrasound cine clips were obtained. The rates of microbubble destruction across the oxygenator and over time were calculated from time‐intensity‐curves. Measurements across the membrane oxygenator were recorded and compared by a repeated‐measures analysis of variance. In vivo, 7 premature fetal lambs were transferred from placental support to the extrauterine environment for neonatal development. Contrast agent boluses were administered for contrast‐enhanced ultrasound (CEUS) examinations. Hemodynamic parameters and serum laboratory values were evaluated before and after the examinations by paired t tests. For oxygenator staining, oxygenator membranes from the in vitro circuit, study animals (n = 4), and control animals (n = 4) were stained for the adherent UCA.Results: In vitro, with all doses (0.1–4 mL), there was no difference in measured parameters across the oxygenator (P ≥ .09). Contrast agent destruction (3%–14%) across the oxygenator was observed at the first pass with a progressive decline in contrast intensity over time. In vivo, there was no difference in hemodynamic parameters or serum laboratory values (P ≥ .08) with any CEUS examination (n = 17). For oxygenator staining, all oxygenator membranes were negative for UCA with lipid staining.Conclusions: The UCA had no detectable effect on the oxygenator or measured parameters in in vitro and in vivo studies, thus providing additional safety data to support the use of CEUS in the setting of extracorporeal support.